Patents by Inventor John Charles Gordon

John Charles Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11944696
    Abstract: A detergent product containing one or more active agents is provided.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: April 2, 2024
    Assignee: The Procter & Gamble Company
    Inventors: Mark Robert Sivik, Gregory Charles Gordon, Frank William Denome, Alyssandrea Hope Hamad-Ebrahimpour, Stephen Joseph Hodson, Brian Patrick Croll, John Gerhard Michael, Andreas Josef Dreher, Paul Dennis Trokhan
  • Patent number: 6051581
    Abstract: There are provided new compounds of formula I: ##STR1## wherein R represents hydrogen or methyl; andn represents 1 or 2;or a pharmaceutically acceptable acid addition salt thereof, together with processes for preparing them, compositions containing them and their use in therapy. Compounds of formula I are expected to be useful in the treatment of psychotic disorders, intellectual impairment disorders and anxiety.
    Type: Grant
    Filed: November 9, 1998
    Date of Patent: April 18, 2000
    Assignee: Astra Aktiebolag
    Inventors: John Charles Gordon, Ronald Conrad Griffith, Robert John Murray, Michael Balestra
  • Patent number: 5902814
    Abstract: There are provided new compounds of formula I: ##STR1## wherein R represents hydrogen or methyl; andn represents 1 or 2;or a pharmaceutically acceptable acid addition salt thereof, together with processes for preparing them, compositions containing them and their use in therapy. Compounds of formula I are expected to be useful in the treatment of psychotic disorders, intellectual impairment disorders and anxiety.
    Type: Grant
    Filed: September 18, 1995
    Date of Patent: May 11, 1999
    Assignee: Astra AB
    Inventors: John Charles Gordon, Ronald Conrad Griffith, Robert John Murray, Michael Balestra